Public Perception of the COVID-19 Vaccine: Literature Review
Abstract
Introduction: Community perceptions of COVID-19 vaccines are responses or acceptance based on the information obtained regarding beliefs about the halal status of vaccines, willingness to be vaccinated, and the capacity of healthcare workers providing the COVID-19 vaccine. This is due to numerous issues affecting information about the COVID-19 vaccine. These facts have encouraged the government to enhance the COVID-19 vaccination program within the community.
Objective: This study aims to explore and analyze the public perception of the COVID-19 vaccine. It seeks to identify key factors influencing attitudes towards the vaccine, including trust in health authorities, misinformation, demographic variables, and socio-political influences. The objective is to provide a comprehensive understanding of the drivers of vaccine acceptance and hesitancy to inform public health interventions.
Method: This writing uses a literature review method. It involves searching for and filtering articles that meet predetermined criteria through inclusion criteria. In this writing, scientific articles were found using Google Scholar with search keywords "community perceptions," "knowledge," and "COVID-19 vaccine."
Result: The study revealed a complex landscape of public perception regarding the COVID-19 vaccine. Trust in health authorities and exposure to misinformation emerged as significant factors impacting perceptions. There is a relationship between knowledge and community behavior, education level and vaccination history with knowledge, religion with community attitudes, and COVID-19 vaccination history.
Conclusion: Knowledge influences community perceptions of the COVID-19 vaccine. Therefore, it is necessary to provide comprehensive and equitable information to all communities about the usefulness, safety of the COVID-19 vaccine, and all updated information regarding the COVID-19 vaccine.
References
2. Indriyanti D. Persepsi Petugas Puskesmas terhadap Pelaksanaan Vaksinasi Covid-19 pada Era New Normal Perceptions of Public Health Center Officers on the Implementation of Covid-19 Vaccination in the New Normal Era. Jurnal Inspirasi. 2021;12(1):29.
3. Kementerian Kesehatan Republik Indonesia. Pencegahan dan Pengendalian Coronavirus Disease (COVID-19). Jakarta: Kementerian Kesehatan Republik Indonesia; 2020. p. 1-214.
4. Kevin N. Hubungan Tingkat Pengetahuan Terhadap Sikap Dan Perilaku Masyarakat Kecamatan Medan Denai Tentang Vaksinasi Covid-19. [Undergraduate thesis]. Medan: Fakultas Kedokteran Universitas Sumatera Utara; 2021.
5. Notoatmojo S. Pendidikan dan Perilaku Kesehatan. Jakarta: PT. Rineka Cipta; 2003.
6. Notoatmodjo S. Metodologi Penelitian Kesehatan. Jakarta: Rineka Cipta; 2010.
7. Nurul H. Gambaran Persepsi Masyarakat Terhadap Pemberian Vaksinasi Covid-19 Di Kecamatan Rappocini Kota Makassar Tahun 2021. [Undergraduate thesis]. Makassar: Uin Alauddin Makassar; 2021.
8. Sunaryo. Psikologi untuk Keperawatan. Jakarta: EGC; 2004.
9. Suharyat Y. Hubungan antara sikap, minat dan perilaku manusia. Jurnal Region. 2009;1(3):1-19.
10. Peraturan Menteri Kesehatan. Peraturan Menteri Kesehatan Republik Indonesia Nomor 12 Tahun 2017 Tentang Penyelenggaraan Imunisasi. Jakarta: Kementerian Kesehatan Republik Indonesia; 2017.
11. Persatuan Dokter Paru Indonesia. Diagnosis dan Penatalaksanaan COVID di Indonesia. Jakarta: PDPI; 2020.
12. Pfizer. Pfizer and BioNTech Conclude Phase 3 Study of COVID-19 Vaccine Candidate, Meeting All Primary Efficacy Endpoints. Pfizer; 2020.
13. Rayclif D, dkk. Gambaran Persepsi Masyarakat Terhadap Vaksinasi COVID-19 di Desa Kamanga Dua Kecamatan Tompaso Kabupaten Minahasa. Jurnal KESMAS. 2022 Jan;11(1): Fakultas Kesehatan Masyarakat Universitas Sam Ratulangi Manado.
14. Rothan H, dkk. The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak. J Autoimmun. 2020; USA.
15. Robbins SP, Coulter M. Organizational Behavior. 15th ed. New Jersey: Pearson; 2013.
16. World Health Organization. Naming the coronavirus disease (COVID-19) and the virus that causes it. [Internet]. WHO; 2020 [cited 2021 May 10].
17. World Health Organization. Global Advisory Committee on Vaccine Safety (GACVS) review of latest evidence of rare adverse blood coagulation events with AstraZeneca COVID-19 Vaccine (Vaxzevria and Covishield). [Internet]. WHO; 2020 [cited 2021 Jun 2].
18. World Health Organization. Indonesia: WHO Coronavirus Disease (COVID-19) Dashboard With Vaccination Data. [Internet]. WHO; 2021 [cited 2021 Jun 2].
19. Zisi L. Persepsi Masyarakat Terhadap Vaksin Covid-19 Di Sumatera Selatan. [Undergraduate thesis]. Palembang: Fakultas Kesehatan Masyarakat Universitas Sriwijaya; 2021.
20. Argista ZL. Persepsi masyarakat terhadap vaksin COVID-19 di Sumatera Selatan. Unpublished manuscript; 2021.
21. Enitan SS, Oyekale AO, Akele RY, Olawuyi KA, Olabisi EO, Nwankiti AJ, et al. Assessment of knowledge, perception, and readiness of Nigerians to participate in the COVID-19 vaccine trial. J Vaccines. 2020;8(1):1-12.
22. Hasyifah N. Gambaran persepsi masyarakat terhadap pemberian vaksinasi COVID-19 di Kecamatan Rappocini Kota Makassar tahun 2021. [Thesis]. Makassar: Universitas Hasanuddin; 2021.
23. Malik AA, McFadden SM, Elharake J, Omer SB. Determinants of COVID-19 vaccine acceptance in the US. EClinicalMedicine. 2020;26:100495.
24. Mohamed NA, Solehan HM, Rani MDM, Ithnin M, Isahak CIC. Knowledge, acceptance, and perception on COVID-19 vaccine among Malaysians: A web-based survey. PLoS ONE. 2021;16(8):e0256110.
25. Rumahorbo KN. Hubungan tingkat pengetahuan terhadap sikap dan perilaku masyarakat Kecamatan Medan Denai tentang vaksinasi COVID-19. [Undergraduate thesis]. Medan: Universitas Sumatera Utara; 2021.
26. Runtuwene R, Tucunan AAT, Rumayar AA. Gambaran persepsi masyarakat terhadap vaksinasi COVID-19 di Desa Kamanga Dua Kecamatan Tompaso Kabupaten Minahasa. Jurnal Kesehatan. 2021;13(2):234-245.
27. Fadlyana E, Rusmil K, Tarigan R, Rahmadi AR, Prodjosoewojo S, Sofiatin Y, et al. A phase III, observer-blind, randomized, placebo-controlled study of the efficacy, safety, and immunogenicity of SARS-CoV-2 inactivated vaccine in healthy adults aged 18–59 years: an interim analysis in Indonesia. Vaccine. 2021;39(44):6520-6528.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-Non Commercial License that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
The content of this website is licensed under a Creative Commons Attribution-ShareAlike 4.0 International (CC BY-SA 4.0) license. 
